Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fate Therapeutics (NQ: FATE )

83.14 USD -5.35 (-6.05%)
Official Closing Price Updated: 7:36 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Fate Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
The Renaissance Of The Moonshot Era
Investing in Potentially World-Altering Innovation The start of the current decade introduced to the world an array of challenges ... 
Tags SLAB FCEL FIXX
From Benzinga
Fate Therapeutics Inc (FATE) Q4 2020 Earnings Call Transcript
FATE earnings call for the period ending December 31, 2020. 
Tags FATE Market News
From Motley Fool
Fate Therapeutics: Q4 Earnings Insights
Shares of Fate Therapeutics (NASDAQ:FATE) were flat in after-market trading after the company reported Q4 results. Quarterly ... 
Tags Market News FATE Earnings
From Benzinga
Fate Therapeutics Reports Fourth Quarter 2020 Financial Results and Highlights Operational Progress
From GlobeNewswire News Releases
Fate Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
From GlobeNewswire News Releases
Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Chart: The 20 Top Stocks Of 2020 By Price Return
In the whirlwind of the pandemic, most businesses experienced chaos. From shuttered physical stores to the rapid rise of online activity, only a select few companies successfully weathered the storm. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Code red — here’s what it means for the stock market now that company insiders are selling shares
The stock market is vulnerable to a decline because of overvaluation, while "reopening" and cyclical stocks have been overplayed. 
Tags IBKR GS CZR
From MarketWatch
Got $5,000 and 5 Years to Wait? Buy These 5 Hot Biotech Stocks Now
Time will always be on the investor's side. 
Tags LXRX FATE JNCE
From Motley Fool
Fate Therapeutics Moves Up In Market Cap Rank, Passing Fox
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Fate Therapeutics Inc (FATE) was identified as having a larger market cap than the smaller end of the S&P... 
Tags Stocks
From Market News Video
2 Best Biotech Stocks to Buy in January
These two companies are at the forefront of innovation during our golden age of biotech. 
Tags JNJ FATE PFE
From Motley Fool
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
Insider buying can be an encouraging signal for investors, particularly when there is uncertainty in the markets, as there has been due to the pandemic and political issues. Here are some insider... 
Tags Stocks / Equities
From Blogs - TalkMarkets
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders were taking ... 
Tags Benzinga REV Group Old Republic International
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags AVEO TVTX CELH
From Benzinga
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Pre-Funded Warrants, and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CLSD SRPT NVAX
From Benzinga
Genetics Stocks Pop After Intellia Offers Update For Gene-Editing Drugs
Intellia Therapeutics offered an update Thursday for its gene-editing programs, helping boost genetics stocks Crispr Therapeutics, Editas Medicine, Fate Therapeutics and Beam Therapeutics. 
From Investor's Business Daily
80 Biggest Movers From Yesterday
Gainers Isoray, Inc. (NYSE: ISR) shares jumped 167.8% to close at $1.42 on Wednesday after the company disclosed that it received ... 
Tags PAVM EYES NCTY
From Benzinga
Fate Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
From GlobeNewswire News Releases
Should Investors Be Watching These Top Biotech Stocks In January? 3 Up 40%+ On Monday
Tags Market News
From StockMarket.com
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News IMGN EIDX
From Benzinga
34 Stocks Moving in Tuesday's Pre-Market Session
Gainers Check-Cap Ltd.. (NASDAQ: CHEK) shares rose 91.8% to $2.78 in pre-market trading after jumping over 215% on Monday. ... 
Tags NSPR LC SRAC
From Benzinga
3 Biotech Stocks That Could Double Your Money in 2021
Clinical trial readouts this year could cause these closely watched biotech stocks to explode overnight. 
Tags Market News EDIT BBIO
From Motley Fool
Fate Therapeutics Announces Proposed Public Offering of $350 Million of Common Stock
From GlobeNewswire News Releases
Strange: Bullish FATE Analysts Actually See -25.48% Downside
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Fate Therapeutics Inc (FATE). The average 12-month price target for FATE — averaging the... 
Tags ETFs
From ETF Channel
Here's a Cancer-Killing Stock to Buy for 2021
"Natural killer" (or NK) cancer therapies are hot right now. Here are two stocks that are early leaders in the field -- one is a buy, and the other one is not. 
Tags FATE NK Market News
From Motley Fool
Here's Why Fate Therapeutics' Data Produced a 38% Jump in the Stock Price
The biotech's natural killer cell therapies have real potential. 
Tags Market News FATE
From Motley Fool
Interesting FATE Put And Call Options For August 2021
Investors in Fate Therapeutics Inc (FATE) saw new options begin trading this week, for the August 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
Noteworthy ETF Outflows: XBI, ARCT, FATE, ARWR
Symbols mentioned in this story: XBI, ARCT, FATE, ARWR Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BCDA CDNA Penny Stocks
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.